Women in Canadian Manufacturing

EcoSynthetix announces Sara Elford to join Board of Directors


July 12, 2021
By Canadian Manufacturing
Presented by:
cmo

BURLINGTON — EcoSynthetix Inc., a renewable chemicals company that produces a portfolio of commercially proven bio-based products, announced that Ms. Sara Elford has been appointed to the Board of Directors, effective immediately.

“Building a company that acts as an agent of change to meet the needs of manufacturers, retailers and end customers with bio-based solutions that are healthier and more sustainable than conventional petroleum-based ingredients requires leadership that is forward thinking. Sara Elford brings a wealth of experience in sustainable technologies and capital markets as a former research analyst covering sustainability and special situations,” said Paul Lucas, Chair of the Board of EcoSynthetix. “The calibre of candidates we reviewed for this position was exceptional and deep which speaks to the market need our technologies address and our ability to attract talent. Ms. Elford was an ideal candidate given her expertise in how innovative technologies go-to-market and her financial acumen. With her appointment, our Board is now 40 percent women with a diverse skill set to support management’s commercialization of our bio-based binders for the wood composites, personal care and paper & paperboard markets.”

Ms. Elford has experience in the capital markets, primarily as a sell-side research analyst, including with Canaccord Genuity as a Director, Research Analyst, Sustainability and Special Situations. Sara is a member of the board of directors of WeCommerce, Xebec Absorption, BQE Water and BioSyent. She previously served on the board of directors of Pure Technologies, Carmanah Technologies, Hydrogenics and TSO3. Ms. Elford is a CFA® charterholder and graduate of Bishop’s University.

EcoSynthetix offers sustainable engineered biopolymers that allow customers to reduce their use of harmful materials, such as formaldehyde and styrene-based chemicals.